Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kobayashi, H.
Right arrow Articles by Terao, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, H.
Right arrow Articles by Terao, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 6, No. 8, 735-742, August 2000
© 2000 European Society of Human Reproduction and Embryology


Uterine physiology

Human myometrial cells in culture express specific binding sites for urinary trypsin inhibitor

Hiroshi Kobayashi1, Yasuyuki Hirashima and Toshihiko Terao

Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Handacho 3600, Hamamatsu, Shizuoka, 431-3192, Japan

Abstract

Urinary trypsin inhibitor (UTI), which is present in amniotic fluid, prevents uterine contractility during pregnancy possibly via specific binding protein mechanisms. To test for the presence of UTI binding sites on the cell surface, we prepared cultured myometrial cells obtained at biopsy from 12 pregnant women and performed binding, competition, and cross-linking experiments using a specific radiolabelled UTI as a ligand. We report for the first time two classes of binding sites of differing affinities. Scatchard analysis at 4°C, using radioiodinated UTI, revealed that UTI binds to 35 000 high affinity binding sites/cell (Kd = 9.1x10–9 mol/l) and 450 000 lower affinity binding sites/cell (Kd = 3.5x10–7 mol/l) in cultured myometrial cells. It appears to be the low affinity site that is internalized, and this has been identified as a protein of ~45 kDa by cross-linking and immunoaffinity labelling studies. Monoclonal antibodies against the NH2-terminal fragment of UTI abrogated specific binding of this protein to the cells. Treatment of the cells with hyaluronidase resulted in >80% inhibition of the [125I]-labelled UTI binding to the cells. These data show that the UTI binding site, which is hyaluronidase sensitive, is expressed on the surface of human uterine myometrial cells to accumulate the UTI molecule during pregnancy.

myometrium/parturition/urinary trypsin inhibitor/UTI/UTI-binding protein

Notes

1 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Handacho 3600, Hamamatsu, Shizuoka, 431-3192, Japan. E-mail: hirame{at}hama-med.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Inagaki, H. Kobayashi, R. Yoshida, Y. Kanada, Y. Fukuda, T. Yagyu, T. Kondo, N. Kurita, T. Kitanaka, Y. Yamada, et al.
Suppression of Urokinase Expression and Invasion by a Soybean Kunitz Trypsin Inhibitor Are Mediated through Inhibition of Src-dependent Signaling Pathways
J. Biol. Chem., September 9, 2005; 280(36): 31428 - 31437.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. S. Soloff, Y.-J. Jeng, M. Ilies, S. L. Soloff, M. G. Izban, T. G. Wood, N. I. Panova, G. V.N. Velagaleti, and G. D. Anderson
Immortalization and characterization of human myometrial cells from term-pregnant patients using a telomerase expression vector
Mol. Hum. Reprod., September 1, 2004; 10(9): 685 - 695.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Schlabritz-Loutsevitch, N. Hellner, R. Middendorf, D. Muller, and J. Olcese
The Human Myometrium as a Target for Melatonin
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 908 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Suzuki, H. Kobayashi, M. Fujie, T. Nishida, M. Takigawa, N. Kanayama, and T. Terao
Kunitz-type Protease Inhibitor Bikunin Disrupts Phorbol Ester-induced Oligomerization of CD44 Variant Isoforms Containing Epitope v9 and Subsequently Suppresses Expression of Urokinase-type Plasminogen Activator in Human Chondrosarcoma Cells
J. Biol. Chem., March 1, 2002; 277(10): 8022 - 8032.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Hirashima, H. Kobayashi, M. Suzuki, Y. Tanaka, N. Kanayama, M. Fujie, T. Nishida, M. Takigawa, and T. Terao
Characterization of Binding Properties of Urinary Trypsin Inhibitor to Cell-associated Binding Sites on Human Chondrosarcoma Cell Line HCS-2/8
J. Biol. Chem., April 20, 2001; 276(17): 13650 - 13656.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.